AIM To systematically review the literature on women with both diabetes in pregnancy(DIP) and depression during or after pregnancy. METHODS In this systematic literature review, PubM ed/MEDLINE and EMBASE were searche...AIM To systematically review the literature on women with both diabetes in pregnancy(DIP) and depression during or after pregnancy. METHODS In this systematic literature review, PubM ed/MEDLINE and EMBASE were searched(13 November 2015) using terms for diabetes(type 1, type 2, or gestational), depression, and pregnancy(no language or date restrictions). Publications that reported on women who had both DIP(any type) and depression or depressive symptoms before, during, or within one year after pregnancy were considered for inclusion. All study types were eligible for inclusion; conference abstracts, narrative reviews, nonclinical letters, editorials, and commentaries were excluded, unless they provided treatment guidance.RESULTS Of 1189 articles identified, 48 articles describing women with both DIP and depression were included(sample sizes 36 to > 32 million). Overall study quality was poor; most studies were observational, and only 12 studies(mostly retrospective database studies) required clinical depression diagnosis. The prevalence of concurrent DIP(any type) and depression in general populations of pregnant women ranged from 0% to 1.6%(median 0.61%; 12 studies). The prevalence of depression among women with gestational diabetes ranged from 4.1% to 80%(median 14.7%; 16 studies). Many studies examined whether DIP was a risk factor for depression or depression was a risk factor for DIP. However, there was no clear consensus for either relationship. Importantly, we found limited guidance on the management of women with both DIP and depression. CONCLUSION Given the increasing prevalence of diabetes and depression, high-quality research and specific guidance for management of pregnant women with both conditions are warranted.展开更多
目的系统评价妊娠期糖尿病(GDM)孕产妇心理障碍的发生率及发生风险。方法计算机检索PubMed、Web of Science、Embase、CINAHL、Cochrane Library、APA PsyINFO、万方、中国知网、维普等数据库,收集GDM孕产妇心理障碍相关研究。检索时限...目的系统评价妊娠期糖尿病(GDM)孕产妇心理障碍的发生率及发生风险。方法计算机检索PubMed、Web of Science、Embase、CINAHL、Cochrane Library、APA PsyINFO、万方、中国知网、维普等数据库,收集GDM孕产妇心理障碍相关研究。检索时限为建库至2022年1月19日。2名研究者独立进行文献质量学评价并提取相关资料,采用Stata 15.0进行Meta分析。结果最终纳入48篇研究,GDM孕产妇孕期压力、焦虑、抑郁、产后抑郁的发生率为25%(95%CI:2%~48%)、49%(95%CI:12%~85%)、23%(95%CI:18%~28%)、15%(95%CI:11%~21%)。GDM是孕期焦虑(OR=1.14,95%CI:1.04~1.25)、抑郁(OR=1.63,95%CI:1.21~2.20)、产后抑郁(OR=1.52,95%CI:1.18~1.96)的危险因素。结论GDM会影响孕产妇的心理健康,医护人员应对孕产妇进行早期心理障碍筛查并给予有针对性的干预措施,帮助维持母婴健康。展开更多
目的:探讨情绪释放疗法对妊娠糖尿病病人抑郁、血糖水平及生活质量的影响。方法:将52例伴有抑郁的妊娠糖尿病病人随机分为对照组和试验组,每组26例。对照组给予护理与健康指导,试验组在对照组的基础上接受情绪释放疗法,每次干预10~15 m...目的:探讨情绪释放疗法对妊娠糖尿病病人抑郁、血糖水平及生活质量的影响。方法:将52例伴有抑郁的妊娠糖尿病病人随机分为对照组和试验组,每组26例。对照组给予护理与健康指导,试验组在对照组的基础上接受情绪释放疗法,每次干预10~15 min,每周2次,干预4周后采用抑郁自评量表(SDS)、妊娠糖尿病孕妇生活质量表(GDMQ)、空腹血糖(FBG)、餐后2 h血糖(2 h PG)进行评价。结果:干预前两组SDS、GDMQ评分比较差异无统计学意义(P>0.05);干预4周后试验组SDS评分相比干预前降低,且低于对照组(P<0.05);试验组GDMQ评分较干预前升高,且高于对照组(P<0.001);干预后试验组FBG、2 h PG相比干预前降低且低于对照组(P<0.001)。结论:情绪释放疗法可有效减轻妊娠糖尿病病人抑郁情绪,改善血糖水平,提高其生活质量。展开更多
文摘AIM To systematically review the literature on women with both diabetes in pregnancy(DIP) and depression during or after pregnancy. METHODS In this systematic literature review, PubM ed/MEDLINE and EMBASE were searched(13 November 2015) using terms for diabetes(type 1, type 2, or gestational), depression, and pregnancy(no language or date restrictions). Publications that reported on women who had both DIP(any type) and depression or depressive symptoms before, during, or within one year after pregnancy were considered for inclusion. All study types were eligible for inclusion; conference abstracts, narrative reviews, nonclinical letters, editorials, and commentaries were excluded, unless they provided treatment guidance.RESULTS Of 1189 articles identified, 48 articles describing women with both DIP and depression were included(sample sizes 36 to > 32 million). Overall study quality was poor; most studies were observational, and only 12 studies(mostly retrospective database studies) required clinical depression diagnosis. The prevalence of concurrent DIP(any type) and depression in general populations of pregnant women ranged from 0% to 1.6%(median 0.61%; 12 studies). The prevalence of depression among women with gestational diabetes ranged from 4.1% to 80%(median 14.7%; 16 studies). Many studies examined whether DIP was a risk factor for depression or depression was a risk factor for DIP. However, there was no clear consensus for either relationship. Importantly, we found limited guidance on the management of women with both DIP and depression. CONCLUSION Given the increasing prevalence of diabetes and depression, high-quality research and specific guidance for management of pregnant women with both conditions are warranted.
文摘目的:探讨情绪释放疗法对妊娠糖尿病病人抑郁、血糖水平及生活质量的影响。方法:将52例伴有抑郁的妊娠糖尿病病人随机分为对照组和试验组,每组26例。对照组给予护理与健康指导,试验组在对照组的基础上接受情绪释放疗法,每次干预10~15 min,每周2次,干预4周后采用抑郁自评量表(SDS)、妊娠糖尿病孕妇生活质量表(GDMQ)、空腹血糖(FBG)、餐后2 h血糖(2 h PG)进行评价。结果:干预前两组SDS、GDMQ评分比较差异无统计学意义(P>0.05);干预4周后试验组SDS评分相比干预前降低,且低于对照组(P<0.05);试验组GDMQ评分较干预前升高,且高于对照组(P<0.001);干预后试验组FBG、2 h PG相比干预前降低且低于对照组(P<0.001)。结论:情绪释放疗法可有效减轻妊娠糖尿病病人抑郁情绪,改善血糖水平,提高其生活质量。
